TFM
RVMD icon

TFC Financial Management’s Revolution Medicines RVMD Stock Holding History

TFC Financial Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37K Buy
+34
New +$4.97K ﹤0.01% 460
2025
Q2 		– Sell
-1
Closed -$36 – 1070
2025
Q1 		$36 Hold
1
– – ﹤0.01% 916
2024
Q4 		$44 Hold
1
– – ﹤0.01% 915
2024
Q3 		$46 Hold
1
– – ﹤0.01% 931
2024
Q2 		$39 Buy
+1
New +$37 ﹤0.01% 926

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

TFC Financial Management's RVMD Position: Q2 2026 in Review

TFC Financial Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 34 shares worth $6.37K. The stake represents ﹤0.01% of the portfolio and ranks #460 among its holdings. This is a return to the name: TFC Financial Management previously reported a position in RVMD as recently as Q1 2025.

TFC Financial Management first reported a position in RVMD in Q2 2024 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • TFC Financial Management held 34 shares of Revolution Medicines worth $6.37K as of Q2 2026.
  • Revolution Medicines was a new TFC Financial Management position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #460 holding.
  • TFC Financial Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.